Literature DB >> 8700110

Effect of phorbol myristate acetate on alpha 1-adrenergic action in cells expressing recombinant alpha 1-adrenoceptor subtypes.

J Vázquez-Prado1, J A García-Sáinz.   

Abstract

We studied the ability of norepinephrine to stimulate [3H]inositol trisphosphate production and calcium mobilization in rat-1 fibroblasts stably expressing the cloned alpha 1-adrenergic subtypes and their sensitivity to phorbol-12-myristate-13-acetate (PMA). It was observed that the three subtypes were able to activate this signal transduction process, but marked differences in efficacy were noted. The order of efficacy was alpha 1a > alpha 1b > alpha 1d in cells with similar receptor densities. The use of PMA blocked the alpha 1d responses at lower concentrations than those needed to block the alpha 1b action; little effect of PMA was observed on effects mediated through alpha 1a-adrenoceptors. These effects of PMA were not observed in cells preincubated overnight with the tumor promoter, suggesting that such actions were mediated through isoform or isoforms of protein kinase C subjected to down-regulation. The repetitive addition of norepinephrine induced desensitization of the alpha 1-adrenergic action in cells expressing any of the three subtypes, and this effect was not altered by overnight pretreatment with PMA. Our data indicate that there are differences in sensitivity to PMA among the alpha 1-adrenoceptor subtypes stably expressed in rat-1 fibroblasts.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8700110

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  9 in total

1.  Roles of the α1A-adrenergic receptor carboxyl tail in protein kinase C-induced phosphorylation and desensitization.

Authors:  Alejandro Cabrera-Wrooman; María Teresa Romero-Ávila; J Adolfo García-Sáinz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-10-05       Impact factor: 3.000

2.  Signaling properties of human alpha(1D)-adrenoceptors lacking the carboxyl terminus: intrinsic activity, agonist-mediated activation, and desensitization.

Authors:  C Ekaterina Rodríguez-Pérez; M Teresa Romero-Avila; Guadalupe Reyes-Cruz; J Adolfo García-Sáinz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-05-21       Impact factor: 3.000

Review 3.  Updates in the function and regulation of α1 -adrenoceptors.

Authors:  Juliana Akinaga; J Adolfo García-Sáinz; André S Pupo
Journal:  Br J Pharmacol       Date:  2019-04-01       Impact factor: 8.739

4.  Protein phosphatase-protein kinase interplay modulates alpha 1b-adrenoceptor phosphorylation: effects of okadaic acid.

Authors:  R Alcántara-Hernández; J Vázquez-Prado; J A Gárcia-Sáinz
Journal:  Br J Pharmacol       Date:  2000-02       Impact factor: 8.739

5.  Phosphorylation and desensitization of alpha1d-adrenergic receptors.

Authors:  J A García-Sáinz; F G Vázquez-Cuevas; M T Romero-Avila
Journal:  Biochem J       Date:  2001-02-01       Impact factor: 3.857

6.  alpha1B-Adrenergic receptor phosphorylation and desensitization induced by transforming growth factor-beta.

Authors:  M Teresa Romero-Avila; C Fabián Flores-Jasso; J Adolfo García-Sáinz
Journal:  Biochem J       Date:  2002-12-01       Impact factor: 3.857

7.  α1B-adrenergic receptors differentially associate with Rab proteins during homologous and heterologous desensitization.

Authors:  Jean A Castillo-Badillo; Omar B Sánchez-Reyes; Marco A Alfonzo-Méndez; M Teresa Romero-Ávila; Guadalupe Reyes-Cruz; J Adolfo García-Sáinz
Journal:  PLoS One       Date:  2015-03-23       Impact factor: 3.240

8.  Stimulation of α1a adrenergic receptors induces cellular proliferation or antiproliferative hypertrophy dependent solely on agonist concentration.

Authors:  Beilei Lei; Debra A Schwinn; Daniel P Morris
Journal:  PLoS One       Date:  2013-08-22       Impact factor: 3.240

Review 9.  Novel Structural Approaches to Study GPCR Regulation.

Authors:  Marco A Alfonzo-Méndez; Rocío Alcántara-Hernández; J Adolfo García-Sáinz
Journal:  Int J Mol Sci       Date:  2016-12-23       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.